rearrangement occurs in each patient and that the type
depends on the rearrangement status of the malignant cell. We now confirm and extend these findings by the detailed analysis of the IgH rearrangement status for a random panel Introduction of 18 childhood B precursor ALL patients. In addition, to investigate the relationship between kinetic behavior of a leuSomatic recombination of the immunoglobulin heavy chain kemic cell population and oligoclonality, rearrangement data (IgH) variable (V H ), diversity (D) and joining (J H ) gene segwere correlated with S-phase fraction. ments is a key event in early B cell differentiation.
1 Recombination occurs in an ordered sequence, D to J H joining precedes V H to D-J H joining, 2 and is mediated by recombination Methods signal sequences (RSS) which flank the different gene segments.
3 Expression of the recombination activating genes 1
Patient materials and 2 (RAG 1/2) has been shown to be sufficient for the initiation of recombination in fibroblasts.
B ALL (CD19 + , CD10 − , cIgM − ), 13 common ALL (CD19 + , amplification of minor clonal rearrangements was achieved applying a two-round semi-nested PCR approach. For each CD10 + , cIgM − ) and four pre-B ALL (CD19 + , CD10 + , cIgM + ). Cytogenetic analysis was routinely performed at diagnosis, patient the first round of amplification was performed with a mixture of all V H -family-specific FR1 primers, omitting the using both the direct method and the 24-h culture method.
primer(s) that amplified a major clonal rearrangement, in combination with consensus joining primer JH26. Thirty cycles were performed with PCR conditions as described for the FR1 Southern analysis PCR. Ten microliters of PCR product was subjected to electrophoresis on a 2% agarose gel in order to separate the PCR The mononuclear cell fraction was isolated by FicollHypaque (1.077 g/cm 3 ; Pharmacia, Uppsala, Sweden) density product from the template genomic DNA. The appropriate area of the gel (300-450 bp) was excised. PCR product was gradient centrifugation prior to cryopreservation. High molecular weight DNA was extracted from cryopreserved BM recovered using the Qiaex gel extraction kit (Diagen, Dü sseldorf, Germany) according to the manufacturer's instructions, samples according to standard techniques. 15 Ten micrograms of DNA was digested with the appropriate restriction endoand dissolved in 25 l water. One microliter of first-round PCR product served as template for 30 cycles of second-round nucleases (Promega, Madison, WI, USA) and transferred onto nitrocellulose filters (Schleicher and Schuell, Dassel, amplification with primers FR3 and JH21, as described. Second-round PCR product was subcloned into pGEM-T vecGermany). Hybridization and washing conditions were as described previously. 16 The H24 probe is a 2.8-kb EcoRI-BglII tor using the pGEM-T vector cloning system (Promega) according to the manufacturer's instructions. Ten positive col-J H fragment. 17 The J␦1 probe is a 1. 
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DXP 5Ј-TTGGGGTGAGGTCTGTGTC-3Ј, DN 5Ј-GAAGGT-GTCTGTGTCACAG-3Ј, DK5Ј-GTCAGGGGGTGTCAGA-CTG-3) in combination with consensus joining primer JH21. For patient p81 primer DN-Reverse (5Ј-CTT-GGAATGResults GGGTTTCTGGCTGGG-3Ј) homologous to the 3Ј-RSS was used in combination with primer FR3 for the amplification of
We performed a detailed analysis of the IgH rearrangement status of the leukemic blasts for a panel of 18 childhood B the V H -DN1 rearrangement. PCR conditions for the D-J H /V H -D PCR were as described for the FR3 PCR.
precursor ALL patients (15 at diagnosis and three at relapse).
Patients were chosen randomly provided that sufficient cryopreserved cells were available. In addition S-phase fraction of the leukemic cell population was determined. Sequencing reactions:
PCR products were directly sequenced with the BRL cycle sequencing kit (BRL, Gaithersburg, MD, USA), using one of the PCR primers end-labeled with 32 P (Amersham International, Buckinghamshire, UK) as
IgH subclones in the majority of B precursor ALL suggested by the manufacturer. Southern analysis of BglII and BamHI/HindIII digested DNA was performed with the H24 JH-probe (Table 1) . On the basis of Southern analysis a distinction between monoclonal and Amplification of minor clonal rearrangements:
Selective oligoclonal was made. Restriction fragment length patterns the basis of the above criteria alone as data on the karyotype was not available. However, this leukemia was considered were considered oligoclonal if either the number of bands exceeded the number of chromosome 14 copies per cell or oligoclonal as sequencing data showed that all three predominant clonal rearrangements (45-A, -A8, -A13) were related by if there were extreme differences in intensity of the bands, indicating the existence of subpopulations. For patient p45 the ongoing rearrangement (presented later). On the basis of Southern analysis 10/18 patients were considered oligoclonal assignment of oligoclonal/monoclonal could not be made on and 8/18 were considered monoclonal (Table 1) . In order to patient p79, V to D-J H joining was considered to account for subclone formation. In this patient a D-J H rearrangement (79-identify minor clonal rearrangements below the Southern analysis detection level, and also to determine the type of sec-B) was identified by PCR and search for minor clonal rearrangements consistently identified 79-B2, which probably ondary IgH rearrangement, we systematically PCR amplified and sequenced V H -D-J H and D-J H rearrangements. A panel is derived from 79-B by V to D-J H joining and exonucleolytic loss of the D-J H junctional region. In order to obtain a relative of six V H -family specific FR1 primers (VH1-6), four D-family specific primers (DLR, DXP, DN, DK) and a consensus V Hquantification of the proportion partially (D-J H ) or nonrearranged IgH loci, we performed Southern analysis with a FR3 primer, was used in combination with consensus J H primers (see Methods). By PCR minor clonal rearrangements gen-VH6 probe (Figure 2 ). VH6 is the most 3Ј-located V H -gene and erated by ongoing IgH rearrangement were identified for is deleted or rearranged upon V H to D-J H joining. The VH6 14/18 (77.8%) patients (Figure 1) . Four of these patients (p44, signal was compared to the signal of a reference probe (3Ј-p57, p74, p76) were considered monoclonal by Southern BCR) by densitometry and the VH6/3Ј-BCR ratio served as analysis.
relative measure for the proportion D-J H rearranged IgH loci. It could be shown that for all but two patients with V H to D-J H joining (p42, p76), a significant proportion of the IgH loci was partially rearranged (VH6/3Ј-BCR ratio: 0.8-2.1)
Type of secondary IgH rearrangement (Table 1) . In patients p42 and p76, the absence of significant germline VH6 signal suggests that the D-J H rearrangement is Minor clonal rearrangements were mostly identified on the present in a small percentage of leukemic cells only. Alternabasis of identical D-J H junctional regions. In these cases, tively, in these patients the VH6 gene may have been deleted sequence analysis of the V H -D junctional regions allowed disin the process of an additional rearrangement (possibly a V H tinction between V H to D-J H joining and V H -replacement. V H to D joining) upstream of the D-J H joining. In patient p45 the to D-J H joining, characterized by cessation of sequence identhigh VH6/3Ј-BCR ratio indicates that a large proportion of the ity in related rearrangements in a region with D-homology, IgH loci is D-J H rearranged and that most identified V H -D-J H was observed in 6/14 patients (p42, p44, p45, p54, p57, p76).
rearrangements represent small clones, not detected by SouthIn all six patients the presence of the expected pre-existing Dern analysis. J H rearrangement was confirmed by PCR amplification with a V H -replacement, characterized by sequence identity in D-family-specific primer homologous to the 5Ј RSS (all visible after 30 PCR cycles) followed by sequence analysis. Also in related rearrangements that extends into the V H -D junctional N-region, [28] [29] [30] was observed in 6/14 patients (p33, p36, p43, ment. Possibly, in this patient a more upstream located RSS mediated V H -replacement. However, this could not be conp74, p75, p78). In these patients we could neither detect preexisting D-J H rearrangements by PCR/oligonucleotide firmed as sequencing data were not available. In addition to V H -replacement and V H to D-J H joining, a hybridization, nor a significant fraction partially rearranged IgH loci by Southern analysis with the VH6 probe (VH6/3Ј-variant type of secondary rearrangement was observed in patient p81. In this patient, related rearrangements shared BCR ratio: below background level, Ͻ0.7). Detectable low VH6 signal in some of these patients is due to contaminating identical V H -D junctional regions in the absence of D-J H homology, which is compatible with V H -D to J H joining. This nonleukemic cells in the bone marrow sample. In all six patients the V H -D junctional N-region shared between related type of rearrangement was confirmed by amplification of the expected preexisting V H -D rearrangement followed by rearrangements was always also completely present in the predominant rearrangement(s), which is compatible with all hybridization with a V H -D junctional region oligonucleotide probe. In patient p45, a variation on the V H to D-J H type of minor clonal rearrangements being derived from the predominant clonal rearrangement(s). It should be noted that in patient rearrangement was seen. 
Discussion
IgH oligoclonality in childhood B precursor ALL as determined by Southern analysis is the result of ongoing rearrangeIn each patient only a single type of secondary rearrangement of the IgH locus. [11] [12] [13] [14] We previously reported a detailed ment (V H to D-J H joining, V H -replacement or V H -D to J H analysis of ongoing IgH rearrangement in four selected oligojoining) was detected and mostly only one of the IgH loci clonal childhood ALL patients, which suggested that only a appeared to be subject to ongoing rearrangement. In two single type of secondary rearrangement occurs in each patients with V H -replacement (p33 and p36) related rearrangepatient. 14 We now substantiate and extend these observations ments were identified for two IgH alleles. It should be noted for a random panel of 18 patients. that for patient p33 the type of secondary rearrangement that
In our patient group 10/18 (55.6%) patients were classified generated rearrangement 33-A2 cannot be determined with as oligoclonal on the basis of Southern analysis. This percentcertainty as additional related rearrangements were not identage is relatively high as compared to previous reports (30-ified. However, the nucleotide sequence of 33-A2 is compat-50%). [8] [9] [10] Possibly, this is due to the fact that not only Southible with V H -replacement and exonucleolytic loss of most of ern patterns with an excess of bands over chromosome 14 the original V H -N-D region and a D-J H rearrangement was copies were classified oligoclonal, but that also differences in not identified in this patient.
band intensity were considered indicative for the presence of In order to investigate a correlation between IgH and TCR␦ minor clonal rearrangements. Alternatively, the patient group rearrangement we compared the TCR␦ rearrangement status we analyzed may be biased for patients with a relatively high for five patients with V H -gene replacement and seven patients initial WBC count as sufficient cryopreserved cells had to be with V H to D-J H joining by Southern analysis with the J␦1 available for the analyses. An association between high WBC probe ( Table 1 ). The first group showed a clearly more count and IgH oligoclonality has been reported. 31 In contrast 'advanced' TCR␦ rearrangement status (two rearranged and to the Southern analysis data, by PCR/sequence analysis we nine deleted alleles) than did patients with V H to D-J H joining demonstrated the presence of subclones that resulted from (four germline, eight rearranged and three deleted alleles).
ongoing IgH rearrangement for 14 of 18 (77.8%) patients. Apparently, ongoing IgH rearrangement occurs in the large majority of patients. In agreement herewith, we previously demonstrated ongoing cross lineage TCR␦ rearrangement in Clonality and S-phase fraction over 80% of B precursor ALL.
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By nucleotide sequence analysis of the V H -D junctional region of multiple related rearrangements, the type of secondAt diagnosis, 6/15 patients were considered monoclonal by Southern analysis (2/15 also by PCR) and 9/15 patients oligoary rearrangement, V H -replacement or V H to D-J H joining can be objectively determined. 14 Moreover, for all patients with clonal by Southern analysis. We compared the percentage of cells in S-phase for monoclonal (for only five patients S-phase V H to D-J H joining the expected pre-existing D-J H rearrangement could be demonstrated, whereas D-J H joinings were fraction was determined) and oligoclonal patients (Table 1, Figure 3 ). The S-phase fraction in the oligoclonal patient group never present in patients with V H -replacement. Taken together these data show that the type of secondary rearrangement that was significantly lower than in the monoclonal patient group (P = 0.004 two-sided Student's t-test). Notably, the two mainly occurs depends on the rearrangement status of the predominant malignant clone. One explanation is that in case of patients that were also monoclonal by PCR analysis (p9, p32) showed the highest percentage of cells in S-phase. A correa DJ/VDJ-rearranged cell, V H to D-J H joining will preferably occur as this type of rearrangement is mediated by a complete lation with white blood cell count (WBC count) or age at diagnosis was not apparent (P у 0.05 two-sided Student's t-test).
RSS. In contrast, V H -replacement depends on a heptamer sig-nal within the original V H -gene 30 and is likely to be a relatively S-phase fraction and treatment failure has been reported. 35 Some authors have reported a worse prognosis for patients inefficient process that only becomes apparent if no partial rearrangements are present. Alternatively, partially rearranged with an oligoclonal IgH rearrangement pattern as compared to 'monoclonal' patients, 8,10,36 whereas others did not confirm alleles may be transcriptionally more active.
Apart from a more 'advanced' IgH rearrangement status in this finding. 37 Although this issue is still not totally resolved, it is possible that a low S-phase fraction in 'oligoclonal' patients the patient group with V H -replacement (VDJ/VDJ) as compared to patients with V H to D-J H joining (VDJ/DJ), we also results in worse prognosis. A good understanding of ongoing IgH rearrangement profound that the TCR␦ locus had clearly undergone more recombination steps in the former group. Apparently, there is a corcesses in childhood ALL is important for the monitoring of minimal residual disease (MRD) by PCR as a pitfall of this relation between rearrangement of the IgH and TCR␦ locus in B precursor ALL cells. Possibly, this is due to prolonged (as approach is loss of tumor marker in the course of the disease. Although we may have missed unrelated minor clonal compared to normal B cells) exposure of the IgH and TCR␦ loci to recombinase activity, for variable periods of time. We rearrangements due to the technical approach we took, our data suggest that for a random patient group V H -replacement previously postulated that prior to leukemic transformation recombinase activity in a preleukemic clone leads to the more compared to monoclonal patients. Possibly, for oligoclonality 435-440. to become apparent by Southern analysis the number of sec- clonal patients. For childhood ALL, a correlation between low
